User 1User 2User 3User 4

    62,825+ Validated

    HealthTech Startups 2026: Validate Your Idea + Field Guide

    $330B+ market, 125+ active companies, FDA + HIPAA gauntlet, payer reimbursement gravity. Get a free AI validation in 120 seconds — and the Field Guide investors are reading.

    0/2000·90 free credits on signup · No card required

    Or get inspired — generate HealthTech ideas
    Early bird€59 €99SAVE €40The HealthTech Founder's Field Guide 2026 — €59 report cover
    TL;DR — HealthTech Startups 2026
    • $330–350B

      2026 digital health TAM, projected $650B+ by 2035 at ~15% CAGR (Grand View, IQVIA, Rock Health).

    • $10.1B

      Raised by US digital health startups in 2025 (Rock Health). AI clinical infra captured ~38%.

    • ~75%

      Failure rate. Top killer: payer reimbursement gap + 12–24 month hospital sales cycles.

    How big is the digital health / healthtech market in 2026?

    The global digital health market is sized between $330–$350 billion in 2026, with multiple research firms (Grand View Research, IQVIA, Fortune Business Insights) projecting growth to $650 billion+ by 2035 at a 15% CAGR. AI clinical infrastructure, ambient documentation and remote patient monitoring are the fastest-growing sub-segments, each compounding above 25% per year.

    What is healthtech (digital health)?

    HealthTech (or digital health) is the application of software, AI, sensors and connected devices to diagnose, treat, deliver or coordinate healthcare. The 2026 market splits into 5 main segments: AI diagnostics & imaging, digital therapeutics & mental health, telehealth & care navigation, healthcare infrastructure (EHR, RCM, interoperability), and biotech AI + wearables + femtech.

    What is SaMD (Software as a Medical Device)?

    SaMD is FDA/IMDRF terminology for software intended to diagnose, treat, cure, mitigate or prevent disease without being part of a hardware device. Most AI clinical tools fall under SaMD and require 510(k) clearance (3–6 months), De Novo (6–12 months) or PMA (1–3 years) depending on risk class. The FDA's 2024 Predetermined Change Control Plan (PCCP) framework now lets cleared AI/ML models update post-market without resubmission.

    Primary sources cited above

    FDA — AI/ML Software as Medical Device HHS — HIPAA for Professionals Rock Health — Digital Health Funding 2025 ONC — TEFCA & FHIR Grand View Research — Digital Health Market CMS — Innovation Center / VBC
    2026 Market Map

    The numbers behind the HealthTech window

    Cross-checked from Grand View, IQVIA, Rock Health, Fortune Business Insights & CMS — distilled into 5 founder-relevant data points.

    Global Digital Health TAM 2026
    $330–350B

    Analysts converge in the mid-$300Bs — and project the market doubling by mid-2030s to $650B+.

    202620302035
    ~15%

    CAGR 2026–2035

    Steady compound growth — clinical AI & RPM sub-segments compound >25%.

    $10.1B

    2025 US Digital Health Raise

    Rock Health 2025 tally; ~38% landed in clinical-AI infra (Abridge, Ambience, OpenEvidence, Hippocratic).

    95%+

    US Hospital EHR Penetration

    Epic + Oracle Cerner own ~70% of acute care — distribution = SMART-on-FHIR.

    $4.9T

    US Healthcare Spend 2026

    ~17.6% of GDP. Digital health is still <8% — massive headroom.

    75%

    Failure Rate

    Top killer: reimbursement gap. See Pear, Babylon, Forward, Cano.

    Live · Jun 2026
    FundingSubtle Medical closes $33M Series C; Morgan Stanley Expansion Capital leads· PR Newswire • M&ARoche acquires PathAI for up to $1B to accelerate AI-powered diagnostics· Fierce Biotech • FundingWhoop valuation triples to $10B on $575M Series G; IPO eyed· TechCrunch • M&AUniversal Health Services to acquire Talkspace· UHS Investor Relations • M&ASectra acquires Oxipit — first CE Class IIB autonomous chest X-ray AI· PR Newswire • M&ARadNet acquires Gleamer for up to €230M — largest radiology-AI provider worldwide· RadNet • ResearchHims & Hers posts $2.35B revenue — first full-year profit· Hims & Hers IR • FundingBig Health closes $23.7M Series C+ for prescription DTx revival· STAT News • FundingDevoted Health closes $366M Series F at decacorn levels· Devoted Health • M&ASword Health acquires Kaia Health for $285M; planning $500M round· Bloomberg • IPOInsilico Medicine IPOs at $293M on HKEX (3696)· Forbes • FundingFunction Health closes $298M Series B at $2.5B valuation· TechCrunch • RegCMS approves Medicare reimbursement for AI coronary plaque analysis· STAT News • FundingOura ring raises $900M Series E at $11B valuation· CNBC • FundingAmbience Healthcare closes $243M Series C for ambient AI scribe + coding· Ambience Healthcare • FundingAbridge doubles valuation to $5.3B in 4 months· TechCrunch • IPOOmada Health IPOs at $19/share (NYSE: OMDA)· Omada Health • IPOHinge Health prices IPO at $437M (NYSE: HNGE)· Reuters • FundingCohere Health raises $90M Series C for AI prior authorization· Fierce Healthcare • RegFDA De Novo for Click Therapeutics CT-132 (migraine DTx)· Business Wire • FundingIsomorphic Labs raises $600M Series A (Thrive, GV, Alphabet)· TechCrunch • Shutdown23andMe files Chapter 11; CEO Anne Wojcicki resigns· Reuters • FundingAbridge raises $250M Series D for ambient AI documentation· Reuters • FundingRad AI raises $60M Series C for generative radiology workflows· PR Newswire • ShutdownForward Health shuts down after raising $400M· Fierce Healthcare • FundingSubtle Medical closes $33M Series C; Morgan Stanley Expansion Capital leads· PR Newswire • M&ARoche acquires PathAI for up to $1B to accelerate AI-powered diagnostics· Fierce Biotech • FundingWhoop valuation triples to $10B on $575M Series G; IPO eyed· TechCrunch • M&AUniversal Health Services to acquire Talkspace· UHS Investor Relations • M&ASectra acquires Oxipit — first CE Class IIB autonomous chest X-ray AI· PR Newswire • M&ARadNet acquires Gleamer for up to €230M — largest radiology-AI provider worldwide· RadNet • ResearchHims & Hers posts $2.35B revenue — first full-year profit· Hims & Hers IR • FundingBig Health closes $23.7M Series C+ for prescription DTx revival· STAT News • FundingDevoted Health closes $366M Series F at decacorn levels· Devoted Health • M&ASword Health acquires Kaia Health for $285M; planning $500M round· Bloomberg • IPOInsilico Medicine IPOs at $293M on HKEX (3696)· Forbes • FundingFunction Health closes $298M Series B at $2.5B valuation· TechCrunch • RegCMS approves Medicare reimbursement for AI coronary plaque analysis· STAT News • FundingOura ring raises $900M Series E at $11B valuation· CNBC • FundingAmbience Healthcare closes $243M Series C for ambient AI scribe + coding· Ambience Healthcare • FundingAbridge doubles valuation to $5.3B in 4 months· TechCrunch • IPOOmada Health IPOs at $19/share (NYSE: OMDA)· Omada Health • IPOHinge Health prices IPO at $437M (NYSE: HNGE)· Reuters • FundingCohere Health raises $90M Series C for AI prior authorization· Fierce Healthcare • RegFDA De Novo for Click Therapeutics CT-132 (migraine DTx)· Business Wire • FundingIsomorphic Labs raises $600M Series A (Thrive, GV, Alphabet)· TechCrunch • Shutdown23andMe files Chapter 11; CEO Anne Wojcicki resigns· Reuters • FundingAbridge raises $250M Series D for ambient AI documentation· Reuters • FundingRad AI raises $60M Series C for generative radiology workflows· PR Newswire • ShutdownForward Health shuts down after raising $400M· Fierce Healthcare •

    Source synthesis: Grand View Research 2026 · IQVIA Institute 2026 · Fortune Business Insights · Rock Health 2025 Funding · CMS NHE

    Early bird · save €40
    HealthTech Founder's Field Guide 2026 cover
    The Field Guide

    What's inside the HealthTech Field Guide 2026

    The institutional research report investors and operators are reading before they cut a HealthTech check. Synthesized from 50+ sources, written for founders — no fluff, no recycled blog content.

    • Digital health TAM/SAM/SOM methodology + 6 sourced data points
    • Segment-by-segment growth: AI Dx, DTx, telehealth, infra, biotech AI
    • FDA decoded: 510(k) vs De Novo vs PMA + new PCCP framework
    • HIPAA + TEFCA + FHIR integration playbook for non-clinicians
    • GTM playbook: payer vs provider vs DTC — cycle length, deal size, veto map
    • Reimbursement map: CPT codes, CMS innovation pathways, value-based contracts
    • 5 post-mortems with extracted lessons (Pear, Babylon, Forward, Olive, Cano)
    • 50+ cited sources — FDA, CMS, ONC, IQVIA, Rock Health, Grand View
    €59€99-40%
    Early bird · ends in 60 days
    Stripe-secured payment· Instant PDF delivery· No account required· 7-day refund window
    Live directory · updated 2026

    125 HealthTech Startups to Know in 2026

    79
    Active
    18
    Public
    15
    Acquired
    5
    Shut down
    66
    AI-native
    $41.1B
    Raised
    Showing 10 of 125
    Company Segment HQ Founded Funding Status
    AI-native

    Foundation-model ("CARE") platform triaging 34 FDA-cleared radiology indications at 1,600+ hospitals.
    Radiology AI
    AI Diagnostics & Imaging
    		 Tel Aviv, Israel 2015 $350M
    Series E 2024 (Goldman Sachs)
    		 Active
    AI-native

    AI care-coordination connecting imaging findings to specialist teams in real time.
    Cardiology / Radiology AI
    AI Diagnostics & Imaging
    		 San Francisco, USA 2016 $251M
    Series D $100M ($1.2B, 2022)
    		 Active
    AI-native

    AI digital pathology for biopharma biomarker discovery; acquired by Roche.
    Pathology AI
    AI Diagnostics & Imaging
    		 Cambridge, USA 2016 $255M
    Acquired by Roche May 2026 (up to $1B)
    		 Acquired
    AI-native

    Multimodal AI combining genomics, imaging and clinical data for precision oncology.
    Genomics + Radiology AI
    AI Diagnostics & Imaging
    		 Chicago, USA 2015 $1,300M
    IPO Jun 2024 (~$6.1B, NASDAQ: TEM)
    		 Public
    AI-native

    First FDA-cleared AI for pathology; PanCancer Detect Breakthrough Device 2025.
    Pathology AI
    AI Diagnostics & Imaging
    		 New York, USA 2018 $126M
    Series B 2021
    		 Active
    AI-native

    Generative AI for radiology reporting and workflow automation.
    Radiology AI
    AI Diagnostics & Imaging
    		 San Francisco, USA 2018 $115M
    Series C $60M Jan 2025
    		 Active
    AI-native

    AI coronary CT angiography for personalised heart-attack prevention.
    Cardiology AI
    AI Diagnostics & Imaging
    		 Denver, USA 2017 $250M
    Series C ext $106M Dec 2024
    		 Active

    Non-invasive AI-generated 3D coronary artery models (FFRct).
    Cardiology AI
    AI Diagnostics & Imaging
    		 Mountain View, USA 2007 $900M
    Convertible notes $98M Mar 2025
    		 Active
    AI-native

    AI echocardiography (EchoGo) detecting heart failure.
    Cardiology AI
    AI Diagnostics & Imaging
    		 Oxford, UK 2017 $105M
    Series C $55M Jul 2025
    		 Active
    AI-native

    Federated-learning AI across hospital consortia for drug discovery.
    Pathology / Oncology AI
    AI Diagnostics & Imaging
    		 Paris, France 2016 $354M
    Sanofi minority $80M 2022 ($1B)
    		 Active

    Funding data from public disclosures, Crunchbase, Rock Health, and company announcements (2026 audit). Outbound links use nofollow.

    IdeaProofIdeaProof Original ResearchFirst-party dataset compiled by IdeaProof editors — cite with attribution.

    The 2026 HealthTech landscape, by the numbers we counted ourselves

    Three micro-studies derived from our 125-company dataset. Methodology at the bottom — citations welcome.

    AI-native vs incumbent split

    53%
    of 125 are AI-native

    66 of 125 list AI/ML as core architecture (vs an LLM wrapper on a legacy EHR or RPM stack).

    "AI-native" = ML/LLM as architectural core, not bolt-on summarization on a 2010-era device or EHR module.

    Top 10 funded HealthTech startups

    1. 1.Altos Labs$3,000M
    2. 2.Devoted Health$2,100M
    3. 3.Butterfly Network$1,500M
    4. 4.Tempus AI$1,300M
    5. 5.Hinge Health$1,100M
    6. 6.Babylon Health$1,100M
    7. 7.Schrödinger$1,100M
    8. 8.Oura$1,100M
    9. 9.Ro$1,027M
    10. 10.Waystar$968M

    Cumulative disclosed funding, USD millions, lifetime to date.

    Segment concentration

    • AI Diagnostics & Imaging25 (20%)
    • DTx, Mental & Chronic Care25 (20%)
    • Telehealth & Care Navigation25 (20%)
    • Healthcare Infrastructure25 (20%)
    • Biotech AI, Wearables & Femtech25 (20%)

    Distribution by IdeaProof segmentation. Even split (~20% each) reflects deliberate stratified sampling, not market-cap weights.

    Methodology

    Dataset: 125 companies tracked by IdeaProof editors via a 5-agent web research sweep (June 2026). Inclusion criteria: (a) HealthTech-primary product, (b) publicly disclosed funding or active product as of Q2 2026, (c) verifiable URL. Funding figures aggregated from Crunchbase, Pitchbook, Rock Health and primary press releases (USD millions, lifetime). AI-native classification verified against product documentation and engineering blog posts. Segmentation uses IdeaProof's 5-category taxonomy. Updated monthly; last refresh visible in the Freshness block above. Citations welcome with attribution to "IdeaProof HealthTech Dataset 2026."

    Live database

    3,200 ideas · 1,000 post-mortems · always-on

    Browse what's been built, what's failed, and where — filtered live for HealthTech.

    Ideas · 3,200+

    HealthTech idea database

    Curated, categorized, with demand signals.

    Explore the catalog

    All industriesLegalTechFinTechAI / ML
    Browse all HealthTech ideas
    Failures · 1,000+

    HealthTech failure database

    Post-mortems with the lesson worth remembering.

    Failures by country

    🇺🇸USA🇬🇧UK🇨🇦Canada🇮🇳India🇦🇺Australia🇳🇬Nigeria
    Explore the failure database
    Founder-killer risks

    What kills 75% of HealthTech startups

    Three patterns appear in every post-mortem from Pear Therapeutics to Babylon, Forward, Olive AI and Cano Health. Know them before you build.

    Existential

    Regulatory

    FDA + HIPAA double-gauntlet

    If your software diagnoses, treats or recommends — you are SaMD. 510(k) is 3–6 months, De Novo 6–12, PMA 1–3 years and $10M+. Layer on HIPAA: PHI mishandling carries $100–$50K per violation, capped at $1.5M/year/category.

    Cashflow

    Reimbursement

    No CPT code, no business

    Pear Therapeutics, Babylon and Forward died from the same wound: brilliant clinical UX, zero reimbursement. Map CMS codes (99453/57/58 for RPM, 0779T for AI cardiac) before you write code. Employer pay-vid contracts are the only short-cut.

    Runway killer

    GTM gravity

    12–24 month hospital cycles

    Health-system procurement is committee-driven (clinical, IT, security, legal, finance). Pilots fund themselves but stall on scale. Faster paths: ambulatory clinics (3–6 months), DTC subscription (immediate) and payer pilots via QHIN integration.

    HealthTech Glossary 2026

    18 terms every HealthTech founder must own

    The vocabulary CMIOs, payer medical directors and FDA reviewers use in your first 10 calls.

    Health Insurance Portability and Accountability ActHIPAA
    US federal law setting national standards for protected health information (PHI). HIPAA Privacy + Security Rules govern any digital product touching patient data; civil penalties run $100–$50,000 per violation, capped at $1.5M/year per category.
    FDA 510(k) Clearance510(k)
    Premarket notification pathway proving a medical device or SaMD is substantially equivalent to a legally marketed predicate. Median FDA review 3–6 months; required for most Class II software-as-a-medical-device tools.
    De Novo ClassificationDe Novo
    FDA pathway for novel low/moderate-risk devices with no predicate. Review 6–12 months; used by first-in-class AI diagnostics (e.g. IDx-DR, Paige Prostate). Establishes a new predicate for future 510(k)s.
    Premarket ApprovalPMA
    FDA pathway for Class III high-risk devices requiring clinical trial evidence of safety and efficacy. Timeline 1–3 years, cost typically $10M+. Used by implantables and life-sustaining digital therapeutics.
    Software as a Medical DeviceSaMD
    IMDRF/FDA classification for software intended to diagnose, treat, cure, mitigate or prevent disease without being part of a hardware device. Regulated under Predetermined Change Control Plans (PCCP) since 2024.
    Electronic Health RecordEHR/EMR
    Longitudinal digital patient chart. US market is dominated by Epic (40%+ acute care) and Oracle Cerner. EHR integration via SMART-on-FHIR is the dominant distribution moat in healthcare infrastructure.
    Fast Healthcare Interoperability ResourcesFHIR
    HL7 open standard (R4) for exchanging healthcare data via REST APIs. Mandated by ONC 21st Century Cures Act since 2022; the primary interoperability layer for new digital health products.
    Health Level Seven InternationalHL7
    Family of healthcare data standards (v2 messaging, CDA documents, FHIR APIs). HL7 v2 still dominates legacy hospital interfaces; FHIR is the modern API-first replacement.
    Trusted Exchange Framework and Common AgreementTEFCA
    ONC framework (live since Dec 2023) enabling nationwide health-data exchange via Qualified Health Information Networks (QHINs). Removes the need for one-off EHR integrations.
    Qualified Health Information NetworkQHIN
    Designated network under TEFCA capable of brokering nationwide health-data exchange. Initial QHINs include Health Gorilla, eHealth Exchange, Epic Nexus, Konza and CommonWell — primary distribution rail for new entrants.
    Revenue Cycle ManagementRCM
    End-to-end financial process from patient registration to final payment: eligibility, coding, claims, denials, AR. US RCM software market ~$50B; AI-native entrants (Waystar, AKASA, Cedar) compress denial rates 30–50%.
    Prior AuthorizationPA
    Payer requirement for advance approval before a service or medication. Avg US PA cost ~$11 per request; AI-driven automation (Cohere Health, Anterior, Tennr) approves 70–90% without human review.
    Digital TherapeuticDTx
    Evidence-based software-only intervention that prevents, manages or treats a disease, often FDA-cleared (e.g. CT-132, EndeavorRx, reSET). Reimbursement remains the category killer — see Pear Therapeutics collapse 2023.
    Remote Patient MonitoringRPM
    Continuous capture of patient physiological data outside the clinic via connected devices. Medicare reimburses RPM under CPT 99453/99457/99458 — a ~$100/patient/month recurring revenue line for providers.
    Continuous Glucose MonitorCGM
    Wearable interstitial-glucose sensor (Dexcom, Abbott Libre) streaming readings every 1–5 minutes. CGM-as-platform plays (Levels, January AI, Function) extend the device into preventive metabolic SaaS.
    Value-Based CareVBC
    Payment model rewarding providers for outcomes and total cost of care rather than fee-for-service volume. VBC capitated contracts are the buyer profile for population-health and care-navigation tools.
    Payvider
    Vertically integrated entity acting as both payer (insurer) and provider (clinic). Examples: Oscar Health, Clover Health, Devoted Health, Kaiser Permanente. Aligned incentives compress care delivery cost.
    Telehealth Parity Law
    State or federal regulation requiring payers to reimburse telehealth visits at parity with in-person care. Post-PHE expirations and shifting state rules are the #1 variable in telehealth unit economics.
    Health Insurance Portability and Accountability ActHIPAA
    US federal law setting national standards for protected health information (PHI). HIPAA Privacy + Security Rules govern any digital product touching patient data; civil penalties run $100–$50,000 per violation, capped at $1.5M/year per category.
    FDA 510(k) Clearance510(k)
    Premarket notification pathway proving a medical device or SaMD is substantially equivalent to a legally marketed predicate. Median FDA review 3–6 months; required for most Class II software-as-a-medical-device tools.
    De Novo ClassificationDe Novo
    FDA pathway for novel low/moderate-risk devices with no predicate. Review 6–12 months; used by first-in-class AI diagnostics (e.g. IDx-DR, Paige Prostate). Establishes a new predicate for future 510(k)s.
    Premarket ApprovalPMA
    FDA pathway for Class III high-risk devices requiring clinical trial evidence of safety and efficacy. Timeline 1–3 years, cost typically $10M+. Used by implantables and life-sustaining digital therapeutics.
    Software as a Medical DeviceSaMD
    IMDRF/FDA classification for software intended to diagnose, treat, cure, mitigate or prevent disease without being part of a hardware device. Regulated under Predetermined Change Control Plans (PCCP) since 2024.
    Electronic Health RecordEHR/EMR
    Longitudinal digital patient chart. US market is dominated by Epic (40%+ acute care) and Oracle Cerner. EHR integration via SMART-on-FHIR is the dominant distribution moat in healthcare infrastructure.
    Fast Healthcare Interoperability ResourcesFHIR
    HL7 open standard (R4) for exchanging healthcare data via REST APIs. Mandated by ONC 21st Century Cures Act since 2022; the primary interoperability layer for new digital health products.
    Health Level Seven InternationalHL7
    Family of healthcare data standards (v2 messaging, CDA documents, FHIR APIs). HL7 v2 still dominates legacy hospital interfaces; FHIR is the modern API-first replacement.
    Trusted Exchange Framework and Common AgreementTEFCA
    ONC framework (live since Dec 2023) enabling nationwide health-data exchange via Qualified Health Information Networks (QHINs). Removes the need for one-off EHR integrations.
    Qualified Health Information NetworkQHIN
    Designated network under TEFCA capable of brokering nationwide health-data exchange. Initial QHINs include Health Gorilla, eHealth Exchange, Epic Nexus, Konza and CommonWell — primary distribution rail for new entrants.
    Revenue Cycle ManagementRCM
    End-to-end financial process from patient registration to final payment: eligibility, coding, claims, denials, AR. US RCM software market ~$50B; AI-native entrants (Waystar, AKASA, Cedar) compress denial rates 30–50%.
    Prior AuthorizationPA
    Payer requirement for advance approval before a service or medication. Avg US PA cost ~$11 per request; AI-driven automation (Cohere Health, Anterior, Tennr) approves 70–90% without human review.
    Digital TherapeuticDTx
    Evidence-based software-only intervention that prevents, manages or treats a disease, often FDA-cleared (e.g. CT-132, EndeavorRx, reSET). Reimbursement remains the category killer — see Pear Therapeutics collapse 2023.
    Remote Patient MonitoringRPM
    Continuous capture of patient physiological data outside the clinic via connected devices. Medicare reimburses RPM under CPT 99453/99457/99458 — a ~$100/patient/month recurring revenue line for providers.
    Continuous Glucose MonitorCGM
    Wearable interstitial-glucose sensor (Dexcom, Abbott Libre) streaming readings every 1–5 minutes. CGM-as-platform plays (Levels, January AI, Function) extend the device into preventive metabolic SaaS.
    Value-Based CareVBC
    Payment model rewarding providers for outcomes and total cost of care rather than fee-for-service volume. VBC capitated contracts are the buyer profile for population-health and care-navigation tools.
    Payvider
    Vertically integrated entity acting as both payer (insurer) and provider (clinic). Examples: Oscar Health, Clover Health, Devoted Health, Kaiser Permanente. Aligned incentives compress care delivery cost.
    Telehealth Parity Law
    State or federal regulation requiring payers to reimburse telehealth visits at parity with in-person care. Post-PHE expirations and shifting state rules are the #1 variable in telehealth unit economics.
    What's inside

    The complete table of contents

    Eight chapters built around one question: should you build this HealthTech idea, or not?

    1. CH 01

      Market at a glance

      $330B → $650B by 2035 · 5 segments · 8 sourced data points.

    2. CH 02

      FDA + HIPAA decoded

      510(k) · De Novo · PMA · PCCP · HIPAA Security Rule with timelines & cost.

    3. CH 03

      Reimbursement playbook

      CPT 99453/57/58 · CMS coverage paths · payvider deal structures.

    4. CH 04

      GTM by buyer

      Hospital vs ambulatory vs payer vs DTC — cycle length, deal size, veto map.

    5. CH 05

      Funding map 2025

      $10.1B Rock Health tally · clinical AI infra · top 25 raises decoded.

    6. CH 06

      5 post-mortems

      Pear · Babylon · Forward · Olive · Cano — lessons extracted, not summarized.

    7. CH 07

      Competitive map

      125-startup landscape · 5-segment heatmap · who to avoid head-on.

    8. CH 08

      90-day build-vs-avoid plan

      Scorecard you can apply Monday morning before you write a line of code.

    Get the Field Guide — €59
    Keep learning

    Go deeper on HealthTech

    HealthTech fundraising benchmarks

    Median round sizes, valuations, dilution & ARR multiples for HealthTech — Pre-Seed to Series C.

    Startup ideas database (3,200+)

    Browse vetted ideas across HealthTech and 30+ industries with demand & competition signals.

    Startup failure database (1,000+)

    Post-mortems of failed startups — including HealthTech — with root-cause analysis.

    Failed HealthTech startups · USA

    US-specific post-mortems — the largest HealthTech market by deal volume.

    Failed startups · UK

    UK NHS-adjacent HealthTech failures and regulatory lessons (Babylon, Push Doctor).

    AI / ML validation

    AI-first plays adjacent to HealthTech: clinical decision support, drug discovery, imaging.

    Data & benchmarks · HealthTech

    HealthTech fundraising benchmarks 2024

    Digital health hit $10.1B in 2024 per Rock Health, with AI-enabled care delivery taking 37% of deals. Series A medians: $15M.

    Pre-SeedUS · 2024
    $800K
    median round
    Pre-money
    $7.6M
    Dilution
    9.5%
    To next round
    18 mo
    SeedUS · 2024
    $4.0M
    median round
    Pre-money
    $14M
    Dilution
    22.2%
    To next round
    20 mo
    ARR multiple
    60×
    Series AUS · 2024
    $14M
    median round
    Pre-money
    $43M
    Dilution
    24.6%
    To next round
    22 mo
    ARR multiple
    18×
    Series BUS · 2024
    $31M
    median round
    Pre-money
    $120M
    Dilution
    20.7%
    To next round
    24 mo
    ARR multiple
    14×
    Key trends
    • GLP-1 and women's health drove 2024 mega-rounds
    • AI scribes/note-taking is the hottest sub-sector
    • Provider-enablement outperforming D2C health
    Notable 2024 deals
    • Tempus IPO$410M
    • Hims Growth—
    • Abridge Series D$250M
    • Transcarent Series D$126M
    Top HealthTech investors · 2024
    GVARCH Venture PartnersAndreessen Horowitz BioOrbiMedGeneral Catalyst
    Explore full HealthTech benchmarksCompare across 24 verticals
    Cross-validate

    Not quite HealthTech? Validate the adjacent thesis.

    Three validators most HealthTech founders should also pressure-test before they commit.

    AI / ML

    When the moat is the model, not the clearance.

    Skip FDA risk: validate AI clinical decision support that ships as workflow software, not as a regulated device.

    Validate AI / ML idea

    FinTech

    If your buyer is a CFO, not a CMO.

    RCM, patient finance, FSA/HSA spend — adjacent healthcare budgets with shorter sales cycles than clinical procurement.

    Validate FinTech idea

    LegalTech

    When the moat is HIPAA-grade compliance.

    Validate compliance automation for healthcare entities — privacy, breach response, BAA orchestration.

    Validate LegalTech idea
    View all industry validators
    FAQ

    HealthTech founders ask

    Early bird · save €40
    HealthTech Founder's Field Guide 2026 cover
    The Field Guide

    What's inside the HealthTech Field Guide 2026

    The institutional research report investors and operators are reading before they cut a HealthTech check. Synthesized from 50+ sources, written for founders — no fluff, no recycled blog content.

    • Digital health TAM/SAM/SOM methodology + 6 sourced data points
    • Segment-by-segment growth: AI Dx, DTx, telehealth, infra, biotech AI
    • FDA decoded: 510(k) vs De Novo vs PMA + new PCCP framework
    • HIPAA + TEFCA + FHIR integration playbook for non-clinicians
    • GTM playbook: payer vs provider vs DTC — cycle length, deal size, veto map
    • Reimbursement map: CPT codes, CMS innovation pathways, value-based contracts
    • 5 post-mortems with extracted lessons (Pear, Babylon, Forward, Olive, Cano)
    • 50+ cited sources — FDA, CMS, ONC, IQVIA, Rock Health, Grand View
    €59€99-40%
    Early bird · ends in 60 days
    Stripe-secured payment· Instant PDF delivery· No account required· 7-day refund window

    Quick Answer: HealthTech Idea Validation

    Validate your HealthTech business idea with AI-powered analysis. Get instant market research, competitor analysis, and success probability for HealthTech startups in 120 seconds.

    Common Questions About healthtech

    How to validate my healthtech idea?

    Is my healthtech idea good?

    healthtech startup validation

    Should I start a healthtech business?

    healthtech market validation

    How to test my healthtech concept

    healthtech Related Terms

    Related concepts and keywords: healthtech

    Related Topics to healthtech

    This topic connects to: How big is the digital health / healthtech market in 2026?, What are the top healthtech startups to know in 2026?, What is the biggest founder-killer risk in healthtech?, How long are healthtech sales cycles to hospitals?, What's inside the HealthTech Founder's Field Guide 2026?, How does HIPAA work for AI / SaaS healthtech tools?, Which healthtech categories are investors funding in 2025–2026?, Can AI replace doctors?, What's the failure rate for healthtech startups?, Is healthtech a good career?, How much do healthtech startups make?, What is the difference between healthtech and digital health?, Are AI medical devices legal?, Which hospital systems use AI the most?, How big is the clinical AI sub-market specifically?, Can ChatGPT replace doctors?, What is the best healthtech software?. Understanding healthtech helps with How big is the digital health / healthtech market in 2026?, What are the top healthtech startups to know in 2026?, What is the biggest founder-killer risk in healthtech?.

    healthtech Validation

    Validate your healthtech business idea using AI-powered analysis. Get instant market research, competitor analysis, and success probability assessment for healthtech startups in 120 seconds.

    About IdeaProof

    This content is provided by IdeaProof, an AI-powered business idea validation platform trusted by 10,000+ entrepreneurs worldwide. IdeaProof uses advanced AI including Claude 3.5 Sonnet and GPT-4 to validate startup ideas in 120 seconds, providing market analysis, competitor research, and investor-ready reports. Founded to help entrepreneurs reduce the 42% startup failure rate caused by no market need.

    Source: IdeaProof.io - AI Business Idea Validator. Content last updated: 2026-07-15. For the most current information, visit https://ideaproof.io.